Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Partnering

Partnering
orange

Innovation + Partnering

The future of cancer therapy is now
orange

Treatment + Care

World Cancer Day 2018
#WeCanICan help fight cancer
blue

Commitment + Responsibility

We support the EFPIA campaign
#WeWontRest
green

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey
orange
Cancer

Cancer
blue
Healthy aging

Healthy aging
green
Health policy

Health policy
green

Innovation + Partnering

Open science in cancer research: everybody wins
orange

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.
Social Channels

FaCEBOOK·1 day

#healthyaging… it starts with nutrition. For some extra energy in the morning, try this healthy breakfast recipe. Nuts and seeds are a fantastic source of healthy fats and may help to lower the risk of heart disease. Learn more about #healthyaging here: bit.ly/HealthyBayer

twitter·13 hours

#Bayer’s Nancy Cook Bruns @EUparliament talking about clinical programs in #heartfailure with high unmet medical ne…

youtube·5 months

The toughest interview for Clinician Scientists
Visit us on Facebook
Visit us on Twitter
Visit us on YouTube
Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2018-05-17

Bayer highlights latest oncology research at ASCO 2018

2018-05-11

Bayer receives approval for Eylea® in China

2018-05-03

Bayer: Operational business held back by currency effects – Major progress with Monsanto acquisition

2018-04-05

Bayer to showcase data from diverse oncology pipeline at AACR 2018

2018-03-26

Bayer announces completion of rolling submission of New Drug Application in the U.S. for larotrectinib for the treatment of TRK fusion cancer
Press center